|
Nicholas Dyson is Professor of Medicine at Harvard Medical School, the James and Shirley Curvey MGH Research Scholar and Scientific Director of the Massachusetts General Hospital Cancer Center.〔(【引用サイトリンク】url=http://www.massgeneral.org/cancer/research/researchlab.aspx?id=1166 )〕 ==Research== The Dyson Lab studies the retinoblastoma protein. Working as a post-doctoral fellow in the laboratory of Dr. Ed Harlow, Dyson demonstrated that the retinoblastoma protein can form complexes ''in vitro'' with the E7 oncoprotein of Human papilloma virus type-16. This result implicated pRB binding to E7 as a step in human papilloma virus-associated carcinogenesis. More recently, Dyson's group has shown that the transcription factor E2F1 is a potent and specific inhibitor of beta-catenin/T-cell factor (TCF)-dependent transcription, and that this function contributes to E2F1-induced apoptosis. As of 2015, Professor Dyson has 140 publications in leading peer-reviewed journals. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Nicholas Dyson」の詳細全文を読む スポンサード リンク
|